A cross-sectional analysis of candidate biomarkers of biological effect in smokers, never-smokers and ex-smokers

Standardisation of spirometry

Miller, M. R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., Crapo, R., Enright, P., van der Grinten, C. P. M., Gustafsson, P., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00034805 · Cited by 15,627 · see citing works

Increase in Circulating Products of Lipid Peroxidation (F2-Isoprostanes) in Smokers — Smoking as a Cause of Oxidative Damage

Morrow, J. D., Frei, B. B., Longmire, A. W., Gaziano, J. M., Lynch, S. M., Shyr, Y., Strauss, W., Oates, J. A., & Roberts, L. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505043321804 · Cited by 1,340 · see citing works

Glutathione Peroxidase-1 in Health and Disease: From Molecular Mechanisms to Therapeutic Opportunities

Lubos, E., Loscalzo, J., & Handy, D. E. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3586 · Cited by 1,280 · see citing works

Oxidative stress and redox regulation of lung inflammation in COPD

Rahman, I., & Adcock, I. M. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00053805 · Cited by 944 · see citing works

Fit-for-Purpose Method Development and Validation for Successful Biomarker Measurement

Lee, J. W., Devanarayan, V., Barrett, Y. C., WEINER, R. S., Allinson, J. L., Fountain, S. T., Keller, S., Weinryb, I., Green, M., Duan, L., et al. (2006) · Pharmaceutical Research · doi:10.1007/s11095-005-9045-3 · Cited by 770 · see citing works

Quantification of Isoprostanes as Indices of Oxidant Stress and the Risk of Atherosclerosis in Humans

Morrow, J. D. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000152605.64964.c0 · Cited by 452 · see citing works

Relation between markers of systemic vascular inflammation and smoking in women

Bermudez, E. A., Rifai, N., Buring, J. E., Manson, J. E., & Ridker, P. M. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02284-1 · Cited by 385 · see citing works

Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes.

Nowak, J., MURRAY, J. J., Oates, J. A., & FitzGerald, G. A. (1987) · Circulation · doi:10.1161/01.cir.76.1.6 · Cited by 382 · see citing works

Scavenger Receptors, Oxidized LDL, and Atherosclerosis

Boullier, A., Bird, D. A., Chang, M.-K., Dennis, E. A., FRIEDMAN, P., Gillotte-Taylor, K., Hörkkö, S., Palinski, W., Quehenberger, O., Shaw, P. X., et al. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03943.x · Cited by 330 · see citing works

Oxidative stress in vascular disease and its pharmacological prevention

Li, H., Horke, S., & Förstermann, U. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.03.007 · Cited by 321 · see citing works

Smoking and smoking cessation—The relationship between cardiovascular disease and lipoprotein metabolism: A review

Campbell, S. C., Moffatt, R. J., & STAMFORD, B. A. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.04.046 · Cited by 298 · see citing works

Atherosclerosis and Oxidative Stress

Yamada, N. (2001) · Cited by 296 · see citing works

Independent association of various smoking characteristics with markers of systemic inflammation in menResults from a representative sample of the general population (MONICA Augsburg Survey 1994/95)

FROHLICH, M. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00260-4 · Cited by 294 · see citing works

Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction

(2001) · PsycEXTRA Dataset · doi:10.1037/e719982007-001 · Cited by 283 · see citing works

Role of Oxidized LDL in Atherosclerosis

Kita, T., Kume, N., Minami, M., Hayashida, K., Murayama, T., Sano, H., Moriwaki, H., Kataoka, H., Nishi, E., Horiuchi, H., et al. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03941.x · Cited by 280 · see citing works

Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease

Institute of Medicine (2010) · National Academies Press eBooks · doi:10.17226/12869 · Cited by 273 · see citing works

Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis

Deo, R., Khera, A., McGuire, D. K., Murphy, S. A., Neto, J. D. P. M., Morrow, D. A., & de Lemos, J. A. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.047 · Cited by 270 · see citing works

Validation of Analytic Methods for Biomarkers Used in Drug Development

Chau, C. H., Rixe, O., McLeod, H. L., & Figg, W. D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4535 · Cited by 241 · see citing works

Oxidative Stress in Pathogenesis of Chronic Obstructive Pulmonary Disease: Cellular and Molecular Mechanisms

Rahman, I. (2005) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:43:1:167 · Cited by 233 · see citing works

Measurement of total antioxidant capacity

Young, I. S. (2001) · Journal of Clinical Pathology · doi:10.1136/jcp.54.5.339 · Cited by 180 · see citing works

Passclaim*: Consensus on Criteria

Aggett, P. J., Antoine, J.-M., Asp, N.-G., Bellisle, F., Contor, L., Cummings, J. H., Howlett, J., Müller, D. J. G., Persin, C., Pijls, L. T. J., et al. (2005) · European Journal of Nutrition · doi:10.1007/s00394-005-1104-3 · Cited by 157 · see citing works

CRP levels are elevated in smokers but unrelated to the number of cigarettes and are decreased by long-term smoking cessation in male smokers

Ohsawa, M., Okayama, A., Nakamura, M., Onoda, T., Kato, K., Itai, K., Yoshida, Y., Ogawa, A., Kawamura, K., & Hiramori, K. (2005) · Preventive Medicine · doi:10.1016/j.ypmed.2005.02.002 · Cited by 139 · see citing works

Decreased blood antioxidant capacity and increased lipid peroxidation in young cigarette smokers compared to nonsmokers: Impact of dietary intake

Bloomer, R. J. (2007) · Nutrition Journal · doi:10.1186/1475-2891-6-39 · Cited by 127 · see citing works

Life-Style and Serum Lipids and Lipoproteins

Yoshiya, H. A. T. A., & Nakajima, K. (2000) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat1994.7.177 · Cited by 115 · see citing works

Oxidized LDL and coronary heart disease

Holvoet, P. (2004) · Acta Cardiologica · doi:10.2143/ac.59.5.2005219 · Cited by 110 · see citing works

Relation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in young men.

Wennmalm, Å., Benthin, G., Granström, E., Persson, L., Petersson, A., & Winell, S. (1991) · Circulation · doi:10.1161/01.cir.83.5.1698 · Cited by 106 · see citing works

Simultaneous and Sensitive Measurement of Anabasine, Nicotine, and Nicotine Metabolites in Human Urine by Liquid Chromatography–Tandem Mass Spectrometry

Xu, X., Iba, M. M., & Weisel, C. P. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.038489 · Cited by 106 · see citing works

The effects of second-hand smoke on biological processes important in atherogenesis

Yuan, H., Wong, L., Bhattacharya, M., Ma, C., Zafarani, M., Yao, M., Schneider, M., Pitas, R. E., & Martins‐Green, M. M. (2007) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-7-1 · Cited by 97 · see citing works

Association Between Plasma Monocyte Chemoattractant Protein-1 Concentration and Cardiovascular Disease Mortality in Middle-Aged Diabetic and Nondiabetic Individuals

Piemonti, L., Calori, G., Lattuada, G., Mercalli, A., Ragogna, F., Garancini, M. P., Ruotolo, G., Luzi, L., & Perseghin, G. (2009) · Diabetes Care · doi:10.2337/dc09-0763 · Cited by 97 · see citing works

Circulating Soluble Intercellular Adhesion Molecule 1 and Subclinical Atherosclerosis: the Coronary Artery Risk Development in Young Adults Study

Gross, M. D., Bielinski, S. J., Suarez-Lopez, J. R., Reiner, A. P., Bailey, K. R., Thyagarajan, B., Carr, J. J., Duprez, D. A., & Jacobs, D. R. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2011.168559 · Cited by 91 · see citing works

Effect of increased fruit and vegetable intake on the susceptibility of lipoprotein to oxidation in smokers

Hininger‐Favier, I., Chopra, M., Thurnham, D. I., Laporte, F., Richard, M.-J., Favier, A. E., & Roussel, A. M. (1997) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1600451 · Cited by 90 · see citing works

Facilitated nitration and oxidation of LDL in cigarette smokers

Yamaguchi, Y., Haginaka, J., Morimoto, S., Fujioka, Y., & KUNITOMO, M. (2005) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2005.01472.x · Cited by 87 · see citing works

Smoking influences the atherogenic potential of low-density lipoprotein

Scheffler, E., Wiest, E., Wöehrle, J., Otto, I., Schulz, I., Huber, L. A., Ziegler, R., & Dresel, H. A. (1992) · Journal of Molecular Medicine · doi:10.1007/bf00184660 · Cited by 82 · see citing works

Ascorbate and Dehydroascorbic Acid as Reliable Biomarkers of Oxidative Stress: Analytical Reproducibility and Long-term Stability of Plasma Samples Subjected to Acidic Deproteinization

Lykkesfeldt, J. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0639 · Cited by 82 · see citing works

Circulating markers of inflammation are related to carotid artery atherosclerosis.

Larsson, P. T., Hallerstam, S., Rosfors, S., & Wallén, N. H. (2005) · PubMed · Cited by 80 · see citing works

Relationship between Biomarkers of Cigarette Smoke Exposure and Biomarkers of Inflammation, Oxidative Stress, and Platelet Activation in Adult Cigarette Smokers

Liu, J., Liang, Q., Frost-Pineda, K., Muhammad-Kah, R. S., Rimmer, L. T., Roethig, H. J., Mendes, P. E., & Sarkar, M. A. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0987 · Cited by 79 · see citing works

Pathogenesis of COPD. Part II. Oxidative-antioxidative imbalance.

Mak, J. (2008) · PubMed · Cited by 73 · see citing works

Biomarkers of Potential Harm Among Adult Smokers and Nonsmokers in the Total Exposure Study

Frost-Pineda, K., Liang, Q., Liu, J., Rimmer, L., Jin, Y., Feng, S., Kapur, S., Mendes, P. E., Roethig, H. J., & Sarkar, M. A. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntq235 · Cited by 71 · see citing works

Significance of the Level of Monocyte Chemoattractant Protein-1 in Human Atherosclerosis-Assessment in Chronic Hemodialysis Patients-

KUSANO, K. F., Nakamura, K., Kusano, H., Nishii, N., Banba, K., Ikeda, T., Hashimoto, K., Yamamoto, M., Fujio, H., Miura, A., et al. (2004) · Circulation Journal · doi:10.1253/circj.68.671 · Cited by 68 · see citing works

Smoking, smoking cessation and inflammatory markers in older Chinese men: The Guangzhou Biobank Cohort Study

Lao, X. Q., Jiang, C. Q., Zhang, W. S., Adab, P., Lam, T. H., Cheng, K. K., & Thomas, G. N. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.06.028 · Cited by 66 · see citing works

Oxidative stress and total antioxidant capacity in human plasma

Buico, A., Cassino, C., Ravera, M., Betta, P., & Osella, D. (2009) · Redox Report · doi:10.1179/135100009x392557 · Cited by 65 · see citing works

Evaluation of biomarkers of exposure and potential harm in smokers, former smokers and never-smokers

Lowe, F., Gregg, E. O., & McEwan, M. (2009) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2009.069 · Cited by 65 · see citing works

Simultaneous determination of four tobacco-specific N-nitrosamines (TSNA) in human urine

Kavvadias, D., Scherer, G., Urban, M. J., Cheung, F., Errington, G., Shepperd, J., & McEwan, M. (2009) · Journal of Chromatography B · doi:10.1016/j.jchromb.2009.03.009 · Cited by 61 · see citing works

A comparison of methods for the measurement of 8-isoPGF 2 α : a marker of oxidative stress

Smith, K. A., Shepherd, J., Wakil, A., & Kilpatrick, E. S. (2011) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2010.010151 · Cited by 59 · see citing works

Role of Marginal Vitamin C Deficiency in Atherogenesis: In Vivo Models and Clinical Studies

Frikke‐Schmidt, H., & Lykkesfeldt, J. (2009) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2009.00420.x · Cited by 57 · see citing works

Effect of Cigarette Smoking on the Oxidant/Antioxidant Balance in Healthy Subjects

Chávez, J., Cano, C., Souki, A. J., Bermúdez, V., Medina, M., Ciszek, A., Amell, A., Vargas, M. E., Reyna, N., Toledo, A., et al. (2007) · American Journal of Therapeutics · doi:10.1097/01.psp.0000249918.19016.f6 · Cited by 56 · see citing works

The Influence of Smoking and of Oral and Transdermal Nicotine on Blood Pressure, and Haematology and Coagulation Indices

Blann, A. D., Steele, C., & McCollum, C. N. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657692 · Cited by 53 · see citing works

A 12‐Month, Randomized, Controlled Study to Evaluate Exposure and Cardiovascular Risk Factors in Adult Smokers Switching From Conventional Cigarettes to a Second‐Generation Electrically Heated Cigarette Smoking System

Roethig, H. J., Feng, S., Liang, Q., Liu, J., Rees, W. A., & Zedler, B. K. (2008) · The Journal of Clinical Pharmacology · doi:10.1177/0091270008315316 · Cited by 53 · see citing works

Erythrocyte antioxidant defense response against cigarette smoking in humans—the glutathione S‐transferase vulnerability

Orhan, H., Evelo, C. T., & Şahin, G. (2005) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.20088 · Cited by 53 · see citing works

Alteration of plasma low density lipoprotein from smokers

Scheffler, E., Huber, L. A., Friihbis, J., Schulz, I., Ziegler, R., & Dresel, H. A. (1990) · Atherosclerosis · doi:10.1016/0021-9150(90)90048-n · Cited by 48 · see citing works

Erythrocyte superoxide dismutase, glutathione peroxidase and catalase activities in healthy male subjects in Republic of Macedonia

Bogdanska, J., Korneti, P., & Todorova, B. (2003) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/bf03657168 · Cited by 45 · see citing works

Dramatic Decline in Circulating Intercellular Adhesion Molecule-1 Concentration on Quitting Tobacco Smoking

Scott, D. A., Stapleton, J., Wilson, R. F., Sutherland, G., Palmer, R. M. J., Coward, P. Y., & GUSTAVSSON, G. (2000) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2000.0304 · Cited by 44 · see citing works

Effect of nicotine replacement and quitting smoking on circulating adhesion molecule profiles (sICAM‐1, sCD44v5, sCD44v6)

Palmer, R. M. J., Stapleton, J., Sutherland, G., Coward, P. Y., Wilson, R. F., & Scott, D. A. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.01067.x · Cited by 44 · see citing works

Lung cancer biomarkers for the assessment of modified risk tobacco products: an oxidative stress perspective

Lowe, F., Luettich, K., & Gregg, E. O. (2013) · Biomarkers · doi:10.3109/1354750x.2013.777116 · Cited by 39 · see citing works

Tobacco smoke biomarkers and cancer risk among male smokers in the Shanghai Cohort Study

Hecht, S. S., Murphy, S. E., Stepanov, I. S., Nelson, H. H., & Yuan, J. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.07.016 · Cited by 38 · see citing works

Antioxidant enzyme activities in healthy Chinese adults: influence of age, gender and smoking*

Ho, S. P., Chan‐Yeung, M., CHOW, K. K. M., IP, M. S. M., & Mak, J. (2005) · Respirology · doi:10.1111/j.1440-1843.2005.00702.x · Cited by 37 · see citing works

Excretion of thromboxane metabolites in healthy women after cessation of smoking.

Rångemark, C., Ciabattoni, G., & Wennmalm, Å. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.6.777 · Cited by 36 · see citing works

Hyperhomocysteinemia and recurrent carotid stenosis

Renata, H., Hillenbrand, A., Liewald, F., & Julian, Z. (2008) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-8-1 · Cited by 36 · see citing works

Isoprostane normalisieren sich rasch nach Beendigung des Zigarettenrauchens bei gesunden Erwachsenen

Oguogho, Lupattelli, Palumbo, & Sinzinger, H. F. (2000) · VASA · doi:10.1024/0301-1526.29.2.103 · Cited by 35 · see citing works

Increased erythrocyte antioxidant status protects against smoking induced hemolysis in moderate smokers

Pannuru, P., Vaddi, D. R., Kindinti, R. R., & Nallanchakravarthula, V. (2011) · Human & Experimental Toxicology · doi:10.1177/0960327110396527 · Cited by 32 · see citing works

Measurement of 8-Iso-Prostaglandin F2α in Biological Fluids as a Measure of Lipid Peroxidation

Tacconelli, S., Capone, M. L., & Patrignani, P. (2010) · Methods in molecular biology · doi:10.1007/978-1-59745-364-6_14 · Cited by 23 · see citing works

Effects of smoking cessation and nicotine substitution on systemic eicosanoid production in man

Saareks, V., Ylitalo, P., Alanko, J., Mucha, I., & Riutta, A. (2001) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100100398 · Cited by 23 · see citing works

Increased serum iron may contribute to enhanced oxidation of low-density lipoprotein in smokers in part through changes in lipoxygenase and catalase

Yoshida, H., Sasaki, K., Hirowatari, Y., Kurosawa, H., Sato, N., Furutani, N., & Tada, N. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.03.018 · Cited by 23 · see citing works

The effects of smoking and its cessation on 8‐epi‐PGF2α and transforming growth factor‐beta 1 in Type 1 diabetes mellitus

Flores, L., Vidal, M., Abián, J., Cases, A., Campistol, J. M., Clària, J., Lario, S., & Esmatjes, E. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01133.x · Cited by 20 · see citing works

Effect of giving up cigarette smoking and restarting in patients with clinically manifested atherosclerosis

Chehne, F., Oguogho, A., Lupattelli, G., Palumbo, B., & Sinzinger, H. F. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2002.0438 · Cited by 20 · see citing works

A single-blinded, single-centre, controlled study in healthy adult smokers to identify the effects of a reduced toxicant prototype cigarette on biomarkers of exposure and of biological effect versus commercial cigarettes

Shepperd, C. J., Newland, N., Eldridge, A. C., Graff, D. W., & Meyer, I. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-690 · Cited by 17 · see citing works

CD40/CD154 system and pro-inflammatory cytokines in young healthy male smokers without additional risk factors for atherosclerosis

Garlichs, C. D., Cicha, I., Raaz, D., Meyer, L., Stumpf, C., Klinghammer, L., Yılmaz, A., & Daniel, W. G. (2009) · Inflammation Research · doi:10.1007/s00011-008-8084-8 · Cited by 17 · see citing works

Variation in Blood Levels of Inflammatory Markers Related and Unrelated to Smoking Cessation in Women

Hammett, C. J. K., Harry Prapavessis, A., Baldi, J. C., Ameratunga, R., Schoenbeck, U., Varo, N., French, J. K., White, H. D., & Stewart, R. (2007) · Preventive Cardiology · doi:10.1111/j.1520-037x.2007.05957.x · Cited by 17 · see citing works

Low and very low density lipoprotein composition and resistance to copper-induced oxidation are not notably modified in smokers

Marangon, K., Herbeth, B., Artur, Y., Esterbauer, H., & Siest, G. (1997) · Clinica Chimica Acta · doi:10.1016/s0009-8981(97)00096-x · Cited by 17 · see citing works

Effects of nicotine replacement therapy on markers of oxidative stress in cigarette smokers enrolled in a smoking cessation program

Petruzzelli, S., Tavanti, L. M., Pulerà, N., Fornai, E., Puntoni, R., Celi, A., & Giuntini, C. (2000) · Nicotine & Tobacco Research · doi:10.1080/713688155 · Cited by 16 · see citing works

Association between Plasma Monocyte Chemoattractant Protein-1 Levels and the Extent of Atherosclerotic Peripheral Artery Disease

Şatıroğlu, Ö., Uydu, H. A., Demi̇r, A., Bostan, M., Atak, M., & Bozkurt, E. (2011) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.224.301 · Cited by 11 · see citing works

Vitamin C-Sources, Physiological Role, Kinetics, Deficiency, Use, Toxicity, and Determination

Doseděl, M., Jirkovský, E., Macáková, K., Krčmová, L., Javorská, L., Pourová, J., Mercolini, L., Remião, F., Nováková, L., Mladěnka, P., et al. (2021) · Nutrients · doi:10.3390/nu13020615 · Cited by 553 · see citing works

Assessing modified risk tobacco and nicotine products: Description of the scientific framework and assessment of a closed modular electronic cigarette

Murphy, J., Gaca, M., Lowe, F., Minet, E., Breheny, D., Prasad, K., Camacho, O., Fearon, I. M., Liu, C., Wright, C., et al. (2017) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2017.09.008 · Cited by 60 · see citing works

Acute pulmonary effects of aerosolized nicotine

Ahmad, S., Zafar, I., Mariappan, N., Husain, M., Wei, C., Vetal, N., Eltoum, I. A., & Ahmad, A. M. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00564.2017 · Cited by 67 · see citing works

Smoking a Dangerous Addiction: A Systematic Review on an Underrated Risk Factor for Oral Diseases

Ahmed, N., Arshad, S., Basheer, S. N., Karobari, M. I., Marya, A., Marya, C. M., Taneja, P., Messina, P., Yean, C. Y., & Scardina, G. A. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182111003 · Cited by 41 · see citing works

Suitability of biomarkers of biological effects (BOBEs) for assessing the likelihood of reducing the tobacco related disease risk by new and innovative tobacco products: A literature review

Scherer, G. (2018) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2018.02.002 · Cited by 36 · see citing works

Effects of occupational exposure to carbon black on peripheral white blood cell counts and lymphocyte subsets

Dai, Y., Niu, Y., Duan, H., Bassig, B. A., Ye, M., Zhang, X., Meng, T., Bin, P., Jia, X., Shen, M., et al. (2016) · Environmental and Molecular Mutagenesis · doi:10.1002/em.22036 · Cited by 34 · see citing works

Assessment of biomarkers of exposure and potential harm, and physiological and subjective health measures in exclusive users of nicotine pouches and current, former and never smokers

Azzopardi, D., Haswell, L. E., Frosina, J., McEwan, M., Gale, N., Thissen, J., Meichanetzidis, F., & Hardie, G. (2022) · Biomarkers · doi:10.1080/1354750x.2022.2148747 · Cited by 36 · see citing works

Changes in levels of biomarkers of exposure and biological effect in a controlled study of smokers switched from conventional cigarettes to reduced-toxicant-prototype cigarettes

Shepperd, C. J., Newland, N., Eldridge, A. C., Haswell, L. E., Lowe, F., Papadopoulou, E., Camacho, O. M., Proctor, C., Graff, D. W., & Meyer, I. (2015) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2015.04.016 · Cited by 31 · see citing works

A randomised, controlled, two-Centre open-label study in healthy Japanese subjects to evaluate the effect on biomarkers of exposure of switching from a conventional cigarette to a tobacco heating product

Gale, N., McEwan, M., Eldridge, A. C., Sherwood, N., Bowen, E., McDermott, S., Holmes, E., Hedge, A., Hossack, S., Camacho, O. M., et al. (2017) · BMC Public Health · doi:10.1186/s12889-017-4678-9 · Cited by 26 · see citing works

Multiplatform Serum Metabolic Phenotyping Combined with Pathway Mapping to Identify Biochemical Differences in Smokers

Kaluarachchi, M. R., Boulangé, C. L., García‐Pérez, I., Lindon, J. C., & Minet, E. (2016) · Bioanalysis · doi:10.4155/bio-2016-0108 · Cited by 24 · see citing works

Dietary Antioxidants and Lung Cancer Risk in Smokers and Non-Smokers

Alsharairi, N. A. (2022) · Healthcare · doi:10.3390/healthcare10122501 · Cited by 24 · see citing works

Increased eryptosis in smokers is associated with the antioxidant status and C-reactive protein levels

Attanzio, A., Frazzitta, A., Vasto, S., Tesoriere, L., Pintaudi, A. M., Livrea, M. A., Cilla, A., & Allegra, M. (2018) · Toxicology · doi:10.1016/j.tox.2018.10.019 · Cited by 24 · see citing works

Historical exposomics and high resolution mass spectrometry

Aurich, D., Miles, O., & Schymanski, E. (2021) · Exposome · doi:10.1093/exposome/osab007 · Cited by 22 · see citing works

The effects of industrial noise exposure on lipid peroxidation and antioxidant enzymes among workers

Hosseinabadi, M. B., Khanjani, N., Ebrahimi, M. H., Mirbadie, S. R., & Biganeh, J. (2019) · International Archives of Occupational and Environmental Health · doi:10.1007/s00420-019-01444-1 · Cited by 18 · see citing works

Melatonin reverses the enhanced oxidative damage to membrane lipids and improves skin biophysical characteristics in former-smokers – A study in postmenopausal women

Sagan, D., Stępniak, J., Gesing, A., Lewiñski, A., & Karbownik‐Lewińska, M. (2017) · Annals of Agricultural and Environmental Medicine · doi:10.5604/12321966.1235174 · Cited by 18 · see citing works

Quantification of plasma and leukocyte vitamin C by high performance liquid chromatography with mass spectrometric detection

Szőcs, A., Vancea, S., Kiss, I., & Donáth-Nagy, G. (2020) · Journal of Analytical Chemistry · doi:10.1134/s1061934820090038 · Cited by 17 · see citing works

Influence of smoking on levels of urinary 8-iso Prostaglandin F2α

van der Plas, A., Pouly, S., Bourdonnaye, G. D. L., Baker, G. S., & Lüdicke, F. (2018) · Toxicology Reports · doi:10.1016/j.toxrep.2018.11.011 · Cited by 17 · see citing works

Biomarkers of exposure and potential harm in exclusive users of electronic cigarettes and current, former, and never smokers

Haswell, L. E., Gale, N., Brown, E. H., Azzopardi, D., McEwan, M., Thissen, J., Meichanetzidis, F., & Hardie, G. (2023) · Internal and Emergency Medicine · doi:10.1007/s11739-023-03294-9 · Cited by 15 · see citing works

Statistical analysis plan for “A randomised, controlled study to evaluate the effects of switching from cigarette smoking to using a tobacco heating product on health effect indicators in healthy subjects”

Camacho, O. M., Hedge, A., Lowe, F., Newland, N., Gale, N., McEwan, M., & Proctor, C. (2020) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2020.100535 · Cited by 14 · see citing works

Integrating chemical, toxicological and clinical research to assess the potential of reducing health risks associated with cigarette smoking through reducing toxicant emissions

McAdam, K. G., Murphy, J., Eldridge, A. C., Meredith, C., & Proctor, C. (2018) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2018.03.005 · Cited by 13 · see citing works

Biomarkers of Exposure and Potential Harm in Exclusive Users of Nicotine Pouches and Current, Former, and Never Smokers: Protocol for a Cross-sectional Clinical Study

Azzopardi, D., Haswell, L. E., Frosina, J., McEwan, M., Gale, N., Thissen, J., Meichanetzidis, F., & Hardie, G. (2022) · JMIR Research Protocols · doi:10.2196/39785 · Cited by 10 · see citing works

Influence of smoking and smoking cessation on levels of urinary 11-dehydro thromboxane B2

van der Plas, A., Pouly, S., Bourdonnaye, G. D. L., Ng, W. T., Baker, G. S., & Lüdicke, F. (2018) · Toxicology Reports · doi:10.1016/j.toxrep.2018.04.005 · Cited by 7 · see citing works

Diet Quality and Biological Risk in a National Sample of Older Americans

Choi, Y. J., Ailshire, J., Kim, J. K., & Crimmins, E. M. (2021) · Journal of Aging and Health · doi:10.1177/08982643211046818 · Cited by 4 · see citing works

Biomarkers of Exposure and Potential Harm in Exclusive Users of Electronic Cigarettes and Current, Former and Never-Smokers: A Cross-Sectional Study Protocol

Gale, N., Haswell, L. E., McEwan, M., Azzopardi, D., Thissen, J., & Hardie, G. (2022) · Journal of Health and Environmental Research · doi:10.11648/j.jher.20220802.17 · Cited by 3 · see citing works

Review of recent lung biomarkers of potential harm/effect for tobacco research

Beattie, E., Edmiston, J. S., Makena, P. S., Mason, E., McEwan, M., & Prasad, K. (2021) · F1000Research · doi:10.12688/f1000research.55411.1 · Cited by 2 · see citing works

The Role of Regulatory Science in Reducing the Public Health Impact of Tobacco Use

Proctor, C., & Liu, C. (2015) · ACS symposium series · doi:10.1021/bk-2015-1207.ch004

How Propolis Prevents Nicotine-Related Lung Damage

Özdemir, İ., Muluk, N. B., Karahan, M. B., Dönmez, D. B., & Cingi, C. (2025) · Journal of Craniofacial Surgery · doi:10.1097/scs.0000000000011614

Significance of 8-iso-PGF2α in cardiovascular diseases

Simeone, P., Liani, R., Lattanzio, S., Frezza, M., Alfonsetti, M., Cipollone, F., & Santilli, F. (2026) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2026.100782

Suitability of biomarkers of biological effects (BOBEs) for assessing the likelihood of reducing the tobacco related disease risk by new and innovative tobacco products: A literature review

Scherer, G. (2018) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2018.02.002 · Cited by 36 · see citing works

Evaluation of biomarkers of exposure and potential harm in smokers, former smokers and never-smokers

Lowe, F., Gregg, E. O., & McEwan, M. (2009) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2009.069 · Cited by 65 · see citing works

Changes in biomarkers of exposure and biomarkers of potential harm after 360 days in smokers who either continue to smoke, switch to a tobacco heating product or quit smoking

Gale, N., McEwan, M., Hardie, G., Proctor, C., & Murphy, J. (2022) · Internal and Emergency Medicine · doi:10.1007/s11739-022-03062-1 · Cited by 41 · see citing works

Study of cardiovascular disease biomarkers among tobacco consumers, part 2: biomarkers of biological effect

Nordskog, B. K., Brown, B. G., Marano, K. M., Campell, L. R., Jones, B. A., & Borgerding, M. F. (2015) · Inhalation Toxicology · doi:10.3109/08958378.2015.1013227 · Cited by 22 · see citing works

Review of biomarkers to assess the effects of switching from cigarettes to modified risk tobacco products

Peck, M. J., Sanders, E. B., Scherer, G., Lüdicke, F., & Weitkunat, R. (2018) · Biomarkers · doi:10.1080/1354750x.2017.1419284 · Cited by 21 · see citing works